Member Info for LochinvarLass

It looks like Calculus have also sold off about 1% of their holdings.

I'm not expecting news until April, because otherwise the presentation would have said by the end of the month, rather than H1 2021.

Again, I'm not sure what impact CEPI will have on al the biotech researchers like Scancell. However, if CEPI can marshal regulatory oversight of CTs, country approvals, GMP, and distribution, that will be grand.

Like every other investor, I would like to see the broad list of firms who have signed up, and I hope that Scancell is on the list as it could shorten time to market for their all their product sets.

I'm not sure what the impact will be on the researchers.

If CEPI can align global regulatory hurdles and align GMP to ensure capacity and quality standards remain high, it will benefit billions.

Gates has been instrumental in reducing child mortality rates in developing countries, and I'm glad to see the Gates Foundation helping solve another global problem. https://www.theguardian.com/world/2017/feb/14/bill-gates-philanthropy-warren-buffett-vaccines-infant-mortality

Bojo, Congratulations on getting a coc-k-a-poo. Your comment has decided me that I definitely need a proper agility course and trainer. Right now the whole place is an agility course for her.

Not quite sure what she'll do if she encounters the stags who have taken over the wee golf course in the early mornings. She's been calm around large dogs barking aggressively and would lick everyone she meets to death (that will have to wait one more week as we were at the vet yesterday). She's seemed very keen to get to the sheep, and I saw one ram leap a 4 foot fence to put some distance between us - I'm afraid that just put ideas into her head. (smiley face).

I'm put LSE on one of handsets so I can check for RNS at 7am - so that's what I plan to check from from 1st April.

Both, I don't think Scancell's social media presence has been very active. The only way they can stop people following them is to either block them or limit who can read their posts.

As for the accounts they follow, I'm sure there are at least 2,000 they could be following - eg researchers, grant organisations, scientific (medical) journals and journalists. Other firms are paying the $99/month to boost their first posts of each day to new people.

In light of the £45BN "spent" on England's T&T (only slightly less than the annual GDP of the 71st ranked country in the world), in my view the Twitter option would be money well spent for Scancell - along with getting someone to line up 2 posts a day (estimate it would take a maximum of 10 minutes to find something, write and submit it to their legal team if needed for approval).

What do you use as a filter? Keen to learn without making too many mistakes.

I spent all my pocket money this year on a ****er spaniel because I knew I needed a dog which loved water. She's full of energy and full of the joys of puppyhood. I'm not sure I could manage two this energetic right now, as much as I'm sure she'd love a companion, but for now, I'll be looking for agility classes/courses. (I'm learning again to take a nap when she does.) Where I am is perfect for dogs, with at least 14 walks of varying difficulty for 4 legged walkers and their owners to enjoy. Do you mind me asking what you have? ATB

Hey Has, Very interested in clean energy. I'm hoping the O-Wind urban turbine makes to market soon, so if you hear anything about it, or similar initiatives I'd be keen to hear about them. ATB.

Can you tell me what it said? I didn't see it.

I'm not going to set an upper limit on the valuation for all product lines until efficacy data is published. My very non-scientific back of the envelope calc for being 1st to market for covidity/universal covid alone is £3.4 based on their current valuation and multiplied by the first mover effect.

I was looking at the news slide (think it is number 19). All the earliest dates are H1 2021, which I take to mean April-June, because March would be Q1 for most companies reporting their short and medium term expected news.

I am looking forward to seeing an update on Trinity Delta's share price value - for me that is the most reliable info to hand.

If/When news on Covidity is announced, I do hope it is in the region of the 2000% gains made by others, but that will probably only happen if Scancell is first to market.

On a separate note, my local medical centre has mentioned that there has been a noticeable drop in the numbers of the usual winter ailments. They plan to incorporate some of the covid practices into their normal procedures to help that continue.

RR, absolutely agree about the quality of the posts mattering.

FYI: I won't be posting/recommending as much as I have a wee pup who is energetic when fully awake, and difficult to settle at night. So matter how many recs you get, add 1 from me, and likely another one from C7 who stated recently that he is sleeping 18 hours a day.

ATVB (All the very best), LL

Personally I'm looking for Scancell RNS on Thursday or Fridays and I'm not expecting any this month as there were no Q1 dates on the presentation. ATB All

Hey C7, It's really good to hear that you are not in any pain and might even be feeling good - I wasn't sure from your wording.

Spring is only around the corner, and the bright splashes croci as the few daffs I see on our walks reminds me that this is the time of growth and renewal. However, right now I don't have the energy to get through the weekend posts, much less trawl through the ones before.

As mentioned before, I'm not expecting news for another 7-8 weeks at the earliest (otherwise it would have said Q1, instead of H1 in the presentation). I'll be looking forward to seeing Trinity Delta revising their valuation on the back of that.

Knows, I had something similar a few weeks ago with the quote price being more than 2p away from the bid price showing. My current platform seems to consistently have a wider margin for AIM stocks....

Have we finally managed to get 700k fully vaccinated yet?

Don't settle for less than having everyone vaccinated properly. Ling vivid complications can affect those who get it post the 1st jab.

Did you see the v-o-x markets presentation last week? There is a news slide.

LSE won't let that link be posted here, so go onto Twitter - reach out to me there if needed and I will DM it. Vi did a short summary last week. ATB as I don't expect to be on line much today

Just wanted to post that I've made an initial investment through my ISA. Hope to adding more soon. ATB

I've been pondering this overnight. Scancell are extremely good at what they do. They have no desire to own the whole value chain - at least not yet.

That said, other companies have seen huge share prices rises on the back of any announcement. I think we are in for a bit of a rollercoaster, at least until the CTs start and the data proves efficacy. ATB, as always, #DYOR and never regret an investment or a position liquidation.